{"id":"https://genegraph.clinicalgenome.org/r/3ed402cb-8ff9-4565-b944-5b6dbdfe781dv1.3","type":"EvidenceStrengthAssertion","dc:description":"*CRELD1* was first reported in relation to autosomal dominant Congenital heart disease in 2003 (Robinson et al., PMID: 12632326).* CRELD1* has been noted to be associated with the following disease entities: Atrioventricular septal defect (AVSD), susceptibility to 2; AVSD, partial, with heterotaxy syndrome; AVSD, Down syndrome-associated; congenital heart defect (CHD); tetralogy of Fallot (TOF); and left ventricular noncompaction (LVNC). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, and phenotypic variability of AVSD, AVSD with heterotaxy syndrome, CHD, and TOF. Therefore, these disease entities have been lumped into one disease entity. The split curation for AVSD, Down syndrome- associated will be curated separately. A missense variant that has been reported in a proband is included in this curation (PMID: 22740159). At least 21 other unique variants (missense, frameshift, splice site) have been reported in 46 probands in 11 publications (PMIDs: 12632326, 15857420, 18076106, 24927998, 22740159, 29054759, 34328347, 21413875, 21080147, 28798025, 36011280). However, these variants were not included in the curation due to either a high minor allele frequency (> 0.00001) in gnomAD v.2.1.1 or a low REVEL score (< 0.7). *CRELD1* variants are incompletely penetrant and require interactions with other risk factors to increase the risk of developing a heart defect. This gene-disease association is also supported by three knockout mouse models that show that *Creld1* is important for VEGF signaling and heart development (PMIDs: 25328912, 24697899, 33773999). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 9/5/2023 (SOP Version 9). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3ed402cb-8ff9-4565-b944-5b6dbdfe781d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/1aa67af6-c8df-4151-98ab-049b69fefd08","calculatedEvidenceStrength":"Limited","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/1aa67af6-c8df-4151-98ab-049b69fefd08_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2023-09-05T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/1aa67af6-c8df-4151-98ab-049b69fefd08_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2023-09-18T17:35:58.173Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1aa67af6-c8df-4151-98ab-049b69fefd08_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/466b2f55-eea9-4718-91b7-b871dc22f438","type":"EvidenceLine","dc:description":"Second variant in the gene identified in the proband","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/466b2f55-eea9-4718-91b7-b871dc22f438_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36011280","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1f5df16-4456-4025-98b9-950f00960d26","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.848G>C (p.Gly283Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351723379"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0788c6dc-2b18-4fd6-bb9b-528b820e7b4b","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.001 (134/129088) in non-Finnish European\nRecurrent variant","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0788c6dc-2b18-4fd6-bb9b-528b820e7b4b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22740159","allele":{"id":"https://genegraph.clinicalgenome.org/r/0656f9ff-e379-4e9c-a2c8-f18153979856","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.985C>T (p.Arg329Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA249434"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a56c8770-e316-4c45-a3c6-03eea72020fa","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.0006 (1/1560) in East Asian\n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a56c8770-e316-4c45-a3c6-03eea72020fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21080147","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa2d2e22-db2d-45b8-bac6-41a1545c630f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.857C>G (p.Pro286Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351723461"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0ea39a31-8fe3-4875-9400-c7af8b2fd130","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.0006 (75/129068) in non-Finnish European\n","calculatedScore":1.5,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ea39a31-8fe3-4875-9400-c7af8b2fd130_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34328347","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a84b91a-e480-4a92-9d7d-1caf74edafd7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.959del (p.Gln320ArgfsTer25)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247873"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/91f270b5-97db-4bb7-9f79-e2130b58610e","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.01 (1877, 129164) in non-Finnish European \n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91f270b5-97db-4bb7-9f79-e2130b58610e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18076106","allele":{"id":"https://genegraph.clinicalgenome.org/r/cbb1689f-6976-40ec-9620-c5ede137c4f6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.1104G>A (p.Gln368=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA290516"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/08363dba-57cd-455a-9596-fb6165eb9df6","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.0002 (24/129136) in non-Finnish European\n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08363dba-57cd-455a-9596-fb6165eb9df6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18076106","allele":{"id":"https://genegraph.clinicalgenome.org/r/808979ea-d539-4804-8835-e6f2dcc210ef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.1011G>A (p.Lys337=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247890"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f2ba248a-686c-4441-b937-7f83059b0590","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.0006 (1/1560) in East Asian","calculatedScore":0.5,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2ba248a-686c-4441-b937-7f83059b0590_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24927998","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa2d2e22-db2d-45b8-bac6-41a1545c630f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f2ba248a-686c-4441-b937-7f83059b0590_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blotting and FQ RT-PCR confirmed the P286R variant to be a gain-of-function variant","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/10c07504-72df-4b07-8667-84d522f4aff2","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.005 (113/24482) in African/African American\nREVEL score: 0.208","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10c07504-72df-4b07-8667-84d522f4aff2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12632326","allele":{"id":"https://genegraph.clinicalgenome.org/r/737f40f2-33e2-44af-81f9-2208552b7c3c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.320G>A (p.Arg107His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA281535"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ae6de4ed-d8ba-4c3a-933d-7379698def14","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.0001 (16/113666) in non-Finnish European \n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae6de4ed-d8ba-4c3a-933d-7379698def14_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18076106","allele":{"id":"https://genegraph.clinicalgenome.org/r/c29a84b4-93aa-46cb-9389-5c20f9d8ead3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.600T>C (p.Phe200=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247738"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f1328360-0132-4fb0-bf1c-3e60a97fa373","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.22 (5489/24944, 554 homozygotes) in African/African American\nREVEL score: 0.051","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1328360-0132-4fb0-bf1c-3e60a97fa373_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29054759","allele":{"id":"https://genegraph.clinicalgenome.org/r/1bb5a084-0be6-4df5-a1c7-a4763c7437a4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.1049-376T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247940"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/dae8ee12-4f1e-4c8c-ab53-2b0f622dccd2","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.16 (1410/8684, 103 homozygotes) in African/African American","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dae8ee12-4f1e-4c8c-ab53-2b0f622dccd2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18076106","allele":{"id":"https://genegraph.clinicalgenome.org/r/4052d0ba-7ee6-43c2-bb59-ca98e821fd51","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.-19-86G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA70000116"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8e9a0c3b-8611-4542-852a-c69948f00eae","type":"EvidenceLine","dc:description":"Two variants in CRELD1 identified in the proband.\nREVEL score: 0.271\n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e9a0c3b-8611-4542-852a-c69948f00eae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36011280","allele":{"id":"https://genegraph.clinicalgenome.org/r/320e4cfe-bd23-4f12-91cb-717f7bf18fc2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.930G>T (p.Glu310Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351724509"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c3176e99-f572-4f06-9265-67565f2efc06","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.7 (18064/24932, 6555 homozygotes) in African/African American\n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3176e99-f572-4f06-9265-67565f2efc06_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29054759","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd0bb045-9928-4e2f-902e-d81d2979982b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.1049-393C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247934"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0c1abfa0-2bb4-4ab6-8d2a-70cbbb56b7a5","type":"EvidenceLine","dc:description":"gnomAD minor allele frequency: 0.015 (515/35438, 5 homozygotes) in Latino/Admixed American","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c1abfa0-2bb4-4ab6-8d2a-70cbbb56b7a5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22740159","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e400b2e-67ac-4e2c-b668-50147299fb23","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.616G>A (p.Ala206Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247744"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bcb4f9bc-09e8-43bd-aa8f-a478b3ef50a9","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.00005 (1/19948) in East Asian\nREVEL score: 0.613","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bcb4f9bc-09e8-43bd-aa8f-a478b3ef50a9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29054759","allele":{"id":"https://genegraph.clinicalgenome.org/r/93c92e0c-670b-4862-bd13-09d87acfff16","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.973G>A (p.Glu325Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247878"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/79537959-a421-4170-b3fd-6b46b200c6bf","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.03 (801/24858, 10 homozygotes) in African/African American\n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79537959-a421-4170-b3fd-6b46b200c6bf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18076106","allele":{"id":"https://genegraph.clinicalgenome.org/r/76ef7884-d476-4b9e-8383-f4d9ae6591f7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.1048+23G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247906"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1ac7d903-011d-48a1-85bd-48792009533c","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.001 (134/129088) in non-Finnish European\nRecurrent variant","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ac7d903-011d-48a1-85bd-48792009533c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28798025","allele":{"id":"https://genegraph.clinicalgenome.org/r/0656f9ff-e379-4e9c-a2c8-f18153979856"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c3fb961c-98f3-4b89-b914-44d54d1b923b","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.0008 (104/129042) in non-Finnish European\nREVEL score: 0.594","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3fb961c-98f3-4b89-b914-44d54d1b923b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12632326","allele":{"id":"https://genegraph.clinicalgenome.org/r/b732965d-502b-46a4-8992-e4a9de6e0624","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.932C>T (p.Thr311Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116206"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b72819c5-8888-4c33-ae48-c7c604257d74","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.00003 (3/113756) in non-Finnish European \n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b72819c5-8888-4c33-ae48-c7c604257d74_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18076106","allele":{"id":"https://genegraph.clinicalgenome.org/r/66c1b763-c94c-4dda-bf32-89be9db34971","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.638-16C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247758"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c7d9661d-3861-4636-b5b6-964f577f1789","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.99 (19948/19950, 9973 homozygotes) in East Asian\nREVEL score: 0.064","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7d9661d-3861-4636-b5b6-964f577f1789_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18076106","allele":{"id":"https://genegraph.clinicalgenome.org/r/e8058b2f-05ce-4c46-811a-a9d025025c62","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.37A>G (p.Met13Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247550"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ad8c0da3-0b3e-4f7c-b0d1-7c4f7413a490","type":"EvidenceLine","dc:description":"gnomAD: MAF: 0.001 (134/129088) in non-Finnish European\nRecurrrent variant","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad8c0da3-0b3e-4f7c-b0d1-7c4f7413a490_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21413875","allele":{"id":"https://genegraph.clinicalgenome.org/r/0656f9ff-e379-4e9c-a2c8-f18153979856"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/af6ff816-a93e-46c7-93ef-15d1e3771028","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.0001 (14/129106) in non-Finnish European\n","calculatedScore":1.5,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/af6ff816-a93e-46c7-93ef-15d1e3771028_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34328347","allele":{"id":"https://genegraph.clinicalgenome.org/r/d437c385-18d8-4acf-9bf5-bca7ef01bedb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.977_984dup (p.Arg329AlafsTer19)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2247879"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e076cbe5-5e37-4c2f-bfa0-41682adb0901","type":"EvidenceLine","dc:description":"gnomAD ninor allele frequency is 0.001 (134/129088) in non-Finnish European. The proband's father and two siblings (1M, 1F) carry the variant with no CHD (consistent with low penetrance)","calculatedScore":0.5,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e076cbe5-5e37-4c2f-bfa0-41682adb0901_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12632326","allele":{"id":"https://genegraph.clinicalgenome.org/r/0656f9ff-e379-4e9c-a2c8-f18153979856"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e076cbe5-5e37-4c2f-bfa0-41682adb0901_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot analysis showed mobility of the mutant protein was slightly retarded, compared with that of wild-type on SDS-PAGE in the presence of reducing agents ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/698206aa-9b7b-435a-8ec0-65ab6524d5b1","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/698206aa-9b7b-435a-8ec0-65ab6524d5b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22740159","allele":{"id":"https://genegraph.clinicalgenome.org/r/11b50e28-e05b-416f-bcbc-e6fb4961e1b0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.793A>G (p.Thr265Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351722653"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b2a2c021-a2a8-42e8-8e4a-5cd898ee162d","type":"EvidenceLine","dc:description":"gnomAD MAF: 0.001 (154/129028) in non-Finnish European","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2a2c021-a2a8-42e8-8e4a-5cd898ee162d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15857420","allele":{"id":"https://genegraph.clinicalgenome.org/r/440d62c4-22a2-45a2-9a86-5fdcf27f23e8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.1194G>A (p.Ala398=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2248013"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3fcc26d4-5cfe-4d2e-ac3a-a310cea9766b","type":"EvidenceLine","dc:description":"REVEL score: 0.212","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fcc26d4-5cfe-4d2e-ac3a-a310cea9766b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34328347","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c6f0101-dc0c-45f7-a99a-89c1628d80ec","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077415.3(CRELD1):c.484C>G (p.Pro162Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116208"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1aa67af6-c8df-4151-98ab-049b69fefd08_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1aa67af6-c8df-4151-98ab-049b69fefd08_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdd7e71c-c7b0-4150-b570-9642bdb59369","type":"EvidenceLine","dc:description":"Genotype does not match human patients","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10a3b4ef-e722-463f-9683-c1b110405a45","type":"Finding","dc:description":"In KO mice, the atria were severely enlarged, the ventricles displayed myocardial hypoplasia, the cardiac wall failed to mature properly with trabeculae being morphologically distinct and not yet compacting and presented with an intra-ventricular shunt (IVS). Lack of myocardial Creld1 causes extracellular matrix remodeling and trabeculation defects by modulation of the Notch1 signaling pathway. Hence, KOMyHC mice die early postnatally due to myocardial hypoplasia. \nCardiac phenotyping, histology, immunohistochemistry, RNA-sequencing, and flow cytometry demonstrated that Creld1 function in the myocardium is essential for heart function and survival.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33773999","rdfs:label":"Beckert mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/90dc7d2c-fa59-450f-8432-7b37d25285c3","type":"EvidenceLine","dc:description":"Genotype does not match human patients","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/286e8754-5c57-45e3-b178-dae19e17be36","type":"Finding","dc:description":"Knock-out CRELD1 mice presented fewer cells and less extracellular matrices in the atrioventricular endocardial cushions than wild-type mice.\nCreld1 knockout mouse model combined with increased VEGFA showed abnormal morphogenic response to VEGFA in Creld1-deficient embryonic hearts, indicating that interaction between CRELD1 and VEGFA has the potential to alter atrioventricular canal morphogenesis \nComplete knockout of Creld1 resulted in embryonic lethality, while heterozygotes were phenotypically normal but displays biochemical abnormalities that predispose the developing heart to an aberrant response to increased VEGFA signaling.\nCRELD1 plays a role in regulating VEGFA and that CRELD1 haploinsufficiency alone causes dysregulation of VEGFA\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25328912","rdfs:label":"Redig knockout mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ef832042-46c4-40e5-949f-513a7dc96044","type":"EvidenceLine","dc:description":"Genotype does not match human patients","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28329a70-ebf0-46ff-bcd9-7105b2b868a6","type":"Finding","dc:description":"Heterozygous (+/Creld1KO) mice were viable and indistinguishable from wild-type (+/+) mice. However, the lack of Creld1 was embryonic lethal, resulting in death between embryonic days 11.0 (E11.0) and E11.5. At E11.0, Creld1 -/- hearts showed impaired formation and remodeling of endocardial cushions and still had the shape of a tube with immature atria and ventricles. Creld1KO embryos displayed normal EMT and normal delamination of ECCs at E10.5. However, the number of mesenchymal cells in the endocardial cushion was clearly reduced","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24697899","rdfs:label":"Mass mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Limited","sequence":6873,"specifiedBy":"GeneValidityCriteria9","strengthScore":3.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/J5iYUeuMmoI","type":"GeneValidityProposition","disease":"obo:MONDO_0005453","gene":"hgnc:14630","modeOfInheritance":"obo:HP_0000006"},"version":"1.3","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_1aa67af6-c8df-4151-98ab-049b69fefd08-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}